Clinical Trial Update: Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated a single bolus dose of NovoSeven in paediatric and adult patients with Haemophilia A or Haemophilia B in a non-blee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 1 | Status: COMPLETED